Withdrawal of Antidementia Drugs in Advanced Dementia (WADAD): a randomized clinical trial and cost-utility analysis

Introduction:Dementia is a major public health concern due to its increasing prevalence, substantial caregiver burden, and high financial costs. Currently, antidementia drugs provide only symptomatic effect. The subject of prescribing these drugs in advanced stages is a matter of substantial debate,...

Full description

Bibliographic Details
Main Author: Rute Filipa Crespo Gonçalves (author)
Format: masterThesis
Language:eng
Published: 2022
Subjects:
Online Access:https://hdl.handle.net/10216/142138
Country:Portugal
Oai:oai:repositorio-aberto.up.pt:10216/142138